Structural modeling of the NS 3 helicase of Tick-borne encephalitis virus and their virtual screening of potent drugs using molecular docking

Interdisciplinary Sciences, Computational Life Sciences
Vijai Singh, Pallavi Somvanshi

Abstract

Homology modeling of NS3 helicase in Tick-borne encephalitis virus using known protein crystal structure was done. Its 3-D structure was evaluated and validated using PROCHECK comprising amino acid residues in favored region of Ramachandran plot. Helicase forms a large family of proteins which ubiquitously distributes in wide variety of organisms. It plays crucial role in transcription and replication of single-stranded viral RNA genomes. Consequently, NS3 represents an interesting target for the development of specific antiviral inhibitors. Several helicase inhibiting effective drugs and analogs were selected and the active amino acid residues were targeted. Levovirin, Ribamidine and Ribavirin were found more potent to inhibit TBEV on the basis of robust binding affinity between protein-drug interactions. This finding may help to understand the nature of helicase and development of specific anti-TBEV therapies.

References

Jan 1, 1990·Annual Review of Microbiology·T J ChambersC M Rice
Dec 5, 1993·Journal of Molecular Biology·A Sali, T L Blundell
Aug 1, 1997·Journal of Clinical Microbiology·I TakashimaN Hashimoto
Sep 1, 1997·Nucleic Acids Research·S F AltschulD J Lipman
Jan 11, 2000·Clinical Microbiology Reviews·P LeyssenJ Neyts
Aug 24, 2004·The Journal of Biological Chemistry·Tessa A NallDavid P Fairlie
Jan 13, 2009·Protein Expression and Purification·Vijai SinghB N Mishra

❮ Previous
Next ❯

Citations

Oct 14, 2014·Advances in Virology·Raquel HernandezAngel Paredes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.